Dr. Adam Asch, MD

Dr. Asch practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Asch's NPI, 1154434405, was assigned on August 17, 2006. Dr. Asch graduated from Sidney Kimmel Medical College in 1979. Dr. Asch's Oklahoma license number on file is 30572.

Dr. Asch's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Asch's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Asch is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Asch to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Asch practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Asch's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Asch is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Asch's licenses on file in 3 states: Oklahoma, North Carolina and New York.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Asch treats.

CMS data shows 517 Medicare services from Dr. Asch across 6 procedure codes in 2024, for 158 Medicare patients. Medicare paid $48,165 for them.

CMS counts 158 Medicare patients who saw Dr. Asch in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Asch's median patient age at 71, with 54% women.

In 2024, Dr. Asch wrote 612 Medicare Part D claims for 99 patients. 63% of them were for generic drugs. CMS names the drug for 429 of them, across 17 drugs with 11 or more claims each, at $2,868,937 in total drug cost. In 2023, CMS named 802 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Asch for performance year 2024, reported as part of a group. Dr. Asch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 78 papers to Dr. Asch, published from 2010 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Cells, Cultured, Thrombospondins and Molecular Sequence Data. Dr. Asch has published most often in Blood. Dr. Asch's most frequent co-authors are Ralph L. Nachman, MD, Sami Ibrahimi, MD and Taha Mahdi Salih Al-Juhaishi, MD.

Dmand AI links Dr. Asch to 6 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Anemia, Aplastic, Carcinoma, Renal Cell and Leukemia, Lymphocytic, Chronic, B-Cell.

CMS Open Payments shows 48 general payments to Dr. Asch from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Incyte Corporation paid the most, $240.

Dmand AI lists 7 awards for Dr. Asch, most recently Research Award in 2001.

Dr. Asch graduated from Sidney Kimmel Medical College in 1979.

Dr. Asch is in network with 13 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.